Jeff is SVP and Europe Market Access Practice Lead
He has 18-years of experience building Health Economic and Outcomes Research, Market Access, Pricing and Health Policy Strategies at the Global and Regional Europe level
Jeff had lead market access strategies for early assets, business development and in-licensing, launch readiness, and in-line market access optimization.
He has held leadership roles with Janssen Pharmaceutica, Galapagos, and UCB Biopharma.
Jeff began his career as a Patient Reported Outcomes Specialist.
He obtained his PhD in Sciences from the Free University of Brussels, Belgium.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.